Loading quotes...
Forecast
The analysts' average price target is €2.86 (-8.92%). The median is €2.86 (-8.92%).
| Buy |
5 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 1.07M | 57.53% |
| Gross profit | 169.98K | 91.83% |
| Net profit | -11.11M | 25.85% |
| EBITDA | -10.6M | 24.90% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.58M |
Number of shares | 434.13K |
52-week high/low | €1,121.28 - €2.09 |
| Dividends | No |
Beta | -0.06 |
P/E ratio | 0.00 |
PEG ratio | 0.00 |
P/B ratio | 0.03 |
P/S ratio | 0.06 |
Company profile
| Name | Jaguar Health |
| CEO | Lisa A. Conte |
| Employees | 47 |
